← Leaderboards
Xiaoqiang Wang
Stanford University
$603,501
Attributed
$906,804
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $451.6K · FY2011–22$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$906,804 · 3
By mechanism
R41$454,955 · 1
R15$451,570 · 1
P41$279 · 1
Top collaborators
- Ming Hu2 shared
- Rashim Singh2 shared
Others in their field
Top investigators on “Enzymes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$83,824,814
- Stuart L Schreiber · Harvard University (Medical School)$49,424,554
- Jay D Keasling · University Of California-Berkeley$47,558,861
- David Heimbrook · Leidos Biomedical Research, Inc.$47,513,682
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
EnzymesPlantsGlycosylationEngineeringColonBaseProteinsOverexpressionBacteriaChemotherapySn-38Pharmaceutical PreparationsDrug DevelopmentBiological Response Modifier TherapyFreeze DryingEscherichia ColiGlucoseGlycosyltransferaseDrug Metabolic DetoxicationDose-LimitingCapsuleClinicDiarrheaCancer Patient
Grant awards (4)
Development of Drug Detoxifying Bacteria for Chemotherapy Induced Gut Injury$55,000
R41 · FY2022 · CA
Development of Drug Detoxifying Bacteria for Chemotherapy Induced Gut Injury$399,955
R41 · FY2021 · CA
UGT engineering for detoxifying anticancer drug SN-38$451,570
R15 · FY2015 · CA · contact PI
STRUCTURAL AND MECHANISTIC STUDIES OF XYLOGLUCAN XYLOSYLTRANSFERASE$279
P41 · FY2011 · RR · contact PI